GS
52
-7
XRAY
34
11
SLB
46
2
NUE
48
-2
PSX
34
4
COST
50
2
AIZ
47
-2
KMB
28
-5
OMC
59
4
LMT
27
-2
STZ
50
7
SPG
55
9
LEG
28
6
AAP
30
3
C
50
-4
NSC
47
-3
MPC
28
2
NKE
28
-2
ADI
47
-2
DHI
45
2
GS
52
-7
XRAY
34
11
SLB
46
2
NUE
48
-2
PSX
34
4
COST
50
2
AIZ
47
-2
KMB
28
-5
OMC
59
4
LMT
27
-2
STZ
50
7
SPG
55
9
LEG
28
6
AAP
30
3
C
50
-4
NSC
47
-3
MPC
28
2
NKE
28
-2
ADI
47
-2
DHI
45
2
Financhill
Back

Eton Pharmaceuticals 10K Form

Buy
56

ETON
Eton Pharmaceuticals

Last Price:
8.29
Seasonality Move:
10.53%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive ETON News And Ratings

See the #1 stock for the next 7 days that we like better than ETON

ETON Financial Statistics

Sales & Book Value

Annual Sales: $31.64M
Cash Flow: $1.26M
Price / Cash Flow: 0
Annual Sales: $0.52
Price / Book: 16.03

Profitability

EPS (TTM): -0.26000
Net Income (TTM): $-6.69M
Gross Margin: $21.06M
Return on Equity: -42.84%
Return on Assets: -21.32%

Eton Pharmaceuticals Earnings Forecast

Key Eton Pharmaceuticals Financial Ratios

  • The Gross Profit Margin over the past 6 years for ETON is 66.56%.
  • The Selling, General & Administrative Expenses for ETON have been equal to 59.83% of Gross Profit Margin.
  • The Research & Development expenses have been 10.50% of Revenue.
  • The Net Earning history of ETON is -2.96% of Total Revenues.
  • Per Share Earnings over the last 6 years have been positive in 3 years.

Eton Pharmaceuticals Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: ETON
CUSIP: 29772L
Website: etonpharma.com

Debt

Debt-to-Equity Ratio: 0.35
Current Ratio: 1.4
Quick Ratio: 1.24

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 15.75

ETON Technical Analysis vs Fundamental Analysis

Buy
56
Eton Pharmaceuticals (ETON) is a Buy

Is Eton Pharmaceuticals a Buy or a Sell?